Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001493152-23-020417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-07 | 2023-06-05 | ABEO | Seshadri Vishwas | CEO, Dir | A - Grant | $0.00 | +336.8K | 501.7K | +204% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-05 | A | A | 336,826 | $0.00 | 501,731 | D | — | — | (F1) The restricted stock will vest one-third on each of June 5, 2024, June 5, 2025 and June 5, 2026. |